There is one clinical trial.
This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.
Description: Change of viral load in upper airway in patients admitted to hospital for COVID-19Measure: Change in viral load Time: 5 days
Description: Change of bacterial load in upper airwayMeasure: Change in bacterial load Time: 5 days
Description: Percentage of patients developing ventilated pneumonia (VAP)Measure: Ventilated associated pneumonia Time: 1 month
Description: Number of days patient is intubatedMeasure: Days to extubation Time: 1 month
Description: Number of days patient is dischargedMeasure: Days to discharge Time: 1 month
Description: Change in C-reactive proteinMeasure: Change in C-reactive protein Time: 5 days
Description: Change in 7-point clinical outcome: 7- Death, 6-Hospitalized on ventilatory or ECMO, 5-Hospitalized on non-invasive ventilation, 4-Hospitalized on supplemental O2, 3-Hospitalized not on O2, 2-Not hospitalized but with limitations, 1-Not hospitalized and no limitationsMeasure: 7-point clinical outcome Time: 1 month
Description: Assessment of total bacterial load on the UV catheter tip on the last day of treatmentMeasure: Catheter tip assessment Time: 5 days
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports